Proteinase K Market

Market Insights on Proteinase K covering sales outlook, demand forecast & up-to-date key trends

Proteinase K Market by Form, Application, End User & Region - Forecast 2022 – 2032

Proteinase K Market Outlook (2022 – 2032)

A summary of Proteinase K Market development:

[157 Pages Report] Global demand for proteinase k is expected to rise at a yearly growth rate of 7.0% Y-o-Y to $48.5 Mn million in 2032, supported by:

high research and development activities and investment by research institutes, biopharmaceutical and others in the development of proteinase K
increasing usage of proteinase K in different applications such as nucleic acid and mitochondrial isolation
growing use of proteinase K in drug discovery and disease diagnosis
introduction of new proteinase K by different market players

In-vitro diagnostics use proteinase K to break down endotoxins that bind to ribonuclease A, lysozyme, and other cationic proteins. Additionally, proteinase K is used in the treatment of paraffin-embedded tissue sections during antibody labelling, digestion of proteins from clinical tissue samples, extraction of mitochondria from hepatic cells, and the analysis of the localization of enzymes on membranes. These significant uses of proteinase K will drive the market globally.

The global market for proteinase K is expected to witness a significant growth rate in terms of value owing to the increasing consumer awareness of health benefits and rising research and development activities. The increasing technological advancements in life science industries would generate a good opportunity for the proteinase K market in the estimated period.

Market Outlook:

Data Points	Market Insights
Market Value 2021	US$ 24.4 Mn
Market Value 2022	US$ 25.9 Mn
Market Value 2032	US$ 48.5 Mn
CAGR 2022-2032	6.5%
Market Share of Top 5 Countries	56%
Key Market Players	Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., F. Hoffmann-La Roche Ltd., New England Biolabs, Worthington Biochemical Corporation, Norgen Biotek Corp., BIORON GmbH, Sds Manager, Sisco Research Laboratories Pvt. Ltd., Bioline (Meridian Biosciences Inc.), Promega Corporation, Codexis, Inc., Amano Enzyme Inc., Advanced Enzymes Technologies Ltd., Biocatalysts Ltd., Amicogen, Dyadic International, BBI Solutions, American Laboratories.

Customize this Report

Let us know your requirement to get
100% FREE customization

Customize Now

Development of Proteinase K in North America Region Drives Global Growth

North America is projected to lead the global proteinase k market, owing to increase in investment in research and development by government organizations, rise in demand of the proteinase in K owing to increase in demand of gene therapy and rising adoption of low cost of the proteinase K product in the region. The region is expected to register a higher growth, attributed to the rise in genetic disorders leading to increase in demand of novel diagnosis and treatments, growing emphasis by healthcare organization and evolving healthcare infrastructure.

According to the United States' National Center for Health Statistics, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of the country, and by 2020, it is projected to grow to an estimated 157 million, with 81 million having multiple conditions. In addition, with the emergence of COVID-19, the use of proteinase K registered increased, and therefore, new products have been developed, which is impacting the US market positively.

Proteinase K Market Download Report Brochure

Opportunities in the Proteinase K Market

A wide range of applications of PCR for in vitro diagnostics and the launch of novel PCR products are some major factors that are anticipated to propel the market growth. PCR has become a standard technique in laboratory biology, gaining popularity primarily due to the COVID-19 pandemic. Use of the technique has been accelerated by the launch of portable & affordable RT-PCR home testing kits. For instance, in April 2022, Laboratory Corporation of America received U.S. FDA’s approval for Pixel, an RT-PCR-based COVID-19 home collection kit. The utility of proteinase K in these molecular biology tests contributes to the growth of the market.

In February 2019, Promega Corporation launched Maxwell RSC miRNA Plasma and Serum Kit for miRNA purification. Proteinase K is an extremely active serine protease enzyme that has extensive cleavage specificity on denatured and native proteins. Proteinase K also cleaves a wide range of peptide bonds and is predominantly utilized to perform enzymatic reactions or cell lysates. Proteinase K is widely used in research studies carried out in industries and research institution. The rise in the demand of next generation sequencing in gene therapy combined with the introduction of novel technologies like CRISPR/Cas9 is anticipated to fuel the market of global proteinase k market.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Sales Analysis of Proteinase K from 2014 to 2021 Vs Market Outlook for 2022 to 2032

The market value for proteinase K is approximately 1.2% of the overall US$ 2.21 Bn of the global proteases market in 2021.

The sale of proteinase K expanded at a CAGR of 5.6% from 2014 to 2021, owing to the advent of the rising demand for genomic studies.

The increasing demand for research and development in genomics in DNA RNA purification in different disease studies and drug development is anticipated to drive the proteinase K market and will further increase sales in the forecasting period. The government of developed as well as developing countries is investing in research and development to improve the overall outcome. The rising demand for rapid purification kits is because of rapid screening, proper purification, and concentration of protein samples.

The increasing participation by the public as well as private players in research and development is projected to drive the market of proteinase K in the forecast period. The increasing funding by different biotechnology and pharmaceutical companies for the development of new medicine and diagnostics tools. Proteinase K is majorly used in biotechnology companies which deal with research related to genetic material to develop treatments for various diseases, which will significantly contribute to the growth of the market.

Proteinase K is mainly used in the purification of genetic material. The increasing demand for gene therapy globally is because of its application in different life-threatening diseases and in different clinical applications such as acquired tissue damage, upper gastrointestinal tract infection, autoimmune disease, and systemic protein deficiency. Thus this will help increase the demand for proteinase K globally.

What are the Key Opportunities for the Proteinase K Market Manufacturers?

Growing healthcare expenditure, low production cost, and wide application are creating high potential growth opportunities for players operating in the global proteinase K market.

The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and blood disorders is projected to drive the proteinase K market globally. For instance, report published by World Cancer Research Fund International, Globally, in 2020, there were 18,094,716 million new cancer cases reported. This is one of the prominent factors to boost the demand for the proteinase K market.

Revenue from the proteinase K market is expected to expand at a relatively higher CAGR due to increasing consumer awareness of health benefits and rising research and development activities. Additionally, over the course of the projected period, market growth is anticipated to be fuelled by good product stability and specificity, as well as low wide application and production costs.

The use of proteinase K is high among gene therapy for hereditary diseases such as diabetes, down syndrome and others. For instance, proteinase K is used as an active ingredient in cancer vaccines to eliminate malignant solid tumour organs and kill cancer cells multiple times.

The global proteinase K market is also driven by factors such as an increase in R&D spending in life science and pharmaceuticals by government organizations. The vast advancements in the proteomics market are leading to new applications in protein library generation for functional genomic studies as proteinase K is an integral part of the RNA and DNA purification process.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining Demand for Proteinase K?

The development of more advanced technology for DNA purification and the good accessibility of other proteases may restrain market expansion throughout the projection period.

The good availability of other proteases will hinder the market expansion in the forested period. The other protease offers multiple advantages over proteinase K such as pepsinogen which is also a broad spectrum protease and possesses less specific activity than proteinase K and thus tends not to cause over digestion and it can be easily inactivated by simply increasing the pH. Hence, this factor will restrain the opportunity for the proteinase K market.

The other substitute for proteinase K is Nagarse, a protease that possesses the same properties as proteinase K, it is very inexpensive unlike proteinase K, and will impact the market in the forecasted period.

Furthermore, the introduction of new sophisticated technologies available for DNA purification is anticipated to restrain market expansion. Protein purification is used in different reactions and as a result of technological advancements, there are various sophisticated technologies that are available. The innovative and new technologies for protein purification offer several advantages, such as technologies and instruments providing results in a few minutes while in the case of proteinase K it takes time for interpretation of results. This will thus restrain the demand in the market.

Additionally, various kits are available on market for protein purification and enzyme removal. These kits are easily available to use and have everything required to isolate pure genomic DNA effectively and quickly using the most recent advancement in silicon membrane spin column technology.

These aforementioned factors will restrain the market growth in the given forecast period.

Country-wise Insights

What Makes the U.S. a Highly Lucrative Market for Proteinase K?

U.S. holds approximately 83.0% share in the North American market in 2021 and is projected to display growth at a lucrative CAGR rate of 7.4% during the forecast period.

By the end of the forecast period, a significant increase in research and development activities and greater use of proteinase K will significantly boost the revenue growth of the U.S. proteinase K market.

The market is expanding as a result of development in PCR tools, increasing use of next-generation sequencing technology, strategic move, and adoption of technologically advanced products from key competitors.

What Makes Japan a Large Market for Proteinase K?

Japan holds a market share of 9.1% in the global market in 2021. Awareness among the general population regarding various treatment options and availability is increasing the overall demand. The government in Japan spending more on healthcare infrastructure and actively participating in organizing various healthcare programs for better patient awareness and trying to avail better diagnosis and treatment plans.

What is the Outlook of Germany in the Proteinase K Market?

Germany holds approximately 25.6% share in the European market in 2021 and is projected to display growth at a lucrative CAGR rate of 7.3% during the forecast period.

Due to the growing medical or healthcare sector, which uses advanced biotechnology research to generate diagnostic tools, Germany is experiencing substantial growth in its biotechnology industry. The country's market for proteinase K is expected to grow as a result of the developing biotechnology sector.

Category-wise Insights

Which Proteinase K Form Is Driving Market Growth?

The lyophilized powder form is expected to present a high growth rate with a market share of 57.0% in 2021 and grow with a CAGR of about 6.8% in the global market in the forecast period. In biotechnology, lyophilization is used to preserve purified proteins, blood samples, vaccines, and other biological materials. The process of removal of water from products after it is frozen and placed under a vacuum to allow ice to change directly from solid to vapour without passing through the liquid phase is called lyophilisation. The product form after this process is called lyophilized powder and is widely used.

Which Application Holds the Highest Market Share?

Isolation and purification of genomic DNA & RNA hold the highest market share value of 56.2% during the year 2021, CAGR rate of 7.0% by the end of the forecast period. The process involves the removal of contaminants from the sample to get pure form and high molecular weight of DNA & RNA. Proteinase K helps to digest unwanted proteins in the sample and provide pure DNA & RNA.

Which End User Benefits the Most with the Sales of Proteinase K Globally?

Biotechnology Companies hold the highest market share value of 46.3% during the year 2021. Proteinase K is widely used to hydrolyse the peptide bonds of proteins into amino acids and peptides. The use of proteinase K is more in the biotechnology companies than the other end users, hence it holds the highest share.

Competitive Landscape

With several competitors in proteinase K sphere, the overall market is highly fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and other substitute launches.

On 8 august 2022, Thermo Fisher Scientific has introduced the Applied Biosystems HIV-1 Genotyping Kit with an assay for research and integrase use only that analyzes HIV-positive samples to find genetic variations that are resistant to antiretroviral therapies.
On 10th May, 2021, New England Biolabs, Inc. announces acquisition of Fluorogenics Limited (FGL), a UK-based provider of lyophilization research and development services.
Similarly, recent developments related to companies manufacturing of proteinase K have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as Per Proteinase K Industry Analysis

Attribute	Details
Forecast Period	2022-2032
Historical Data Available for	2014-2022
Market Analysis	US$ Mn for Value
Key Regions Covered	North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered	U.S., Canada Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC countries, South Africa, North Africa
Key Market Segments Covered	Form, Application, End User and Region
Key Companies Profiled	Thermo Fisher Scientific Inc. Merck KGaA Qiagen N.V. F. Hoffmann-La Roche Ltd. New England Biolabs Worthington Biochemical Corporation Norgen Biotek Corp. BIORON GmbH Sds Manager Sisco Research Laboratories Pvt. Ltd. Bioline (Meridian Biosciences Inc.) Promega Corporation Codexis, Inc. Amano Enzyme Inc. Advanced Enzymes Technologies Ltd. Biocatalysts Ltd. Amicogen Dyadic International BBI Solutions American Laboratories
Pricing	Available upon Request

Key Market Segments Covered in Proteinase K Industry Research

By Form:

Lyophilized Powder Form
Liquid Form

By Application:

Isolation and Purification of Genomic DNA & RNA
In situ Hybridization
Mitochondria Isolation
Enzyme Removal

By End User:

Contract Research Organization
Academic Institutes
Biotechnology Companies
Diagnostic Laboratories

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Frequently Asked Questions

How much is the proteinase K market worth in 2021?

The global proteinase K market is worth around US$ 24.4 Mn in 2021 and is expected to present a high growth at a CAGR rate of 6.5% by the end of the forecast period.

What is the sales forecast for the proteinase K market through 2032?

The proteinase K market is expected to reach US$ 48.5 Mn by the end of 2032, with sales revenue anticipated to grow at 6.5% CAGR.

Which are the top 5 countries driving demand for proteinase K?

The U.S., Canada, India, Japan, and Germany are expected to drive demand for the proteinase K industry.

Who are the key players in the proteinase K?

Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., F. Hoffmann-La Roche Ltd., New England Biolabs, Worthington Biochemical Corporation, Norgen Biotek Corp., BIORON GmbH, SdsManager, Sisco Research Laboratories Pvt. Ltd., Bioline (Meridian Biosciences Inc.) are some of the key players within the proteinase K market space.

Who are the key producers in the proteinase K?

Proteinase K are mostly produced in the U.S. and Japan. This region's market expands more rapidly than the rest of the world.

What is the North American market outlook for proteinase K?

One of the major markets for proteinase K is North America, with market share of about 83.0%. in the year 2021.

What are the key trends shaping the proteinase K industry?

Awareness among people, increase in research and development by the manufacturers, good product stability and specificity are some of the key trends in the industry.

What was the last 5 years’ CAGR value growth for the proteinase K market?

From 2014-2021, the market for proteinase K expanded at the rate of 5.6%.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply-Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage/ Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Development/Innovation Trends

4. Key Success Factors

4.1. Promotional Strategies, By Key Manufacturers

4.2. Key Regulations

4.3. Adoption Rate, By Region

4.4. Value Chain Analysis

4.5. PESTEL Analysis

4.6. Porter’s Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

5.1.2. Global Healthcare Expenditure

5.1.3. Global Proteases Market

5.2. Forecast Factors - Relevance & Impact

5.2.1. Key Player’s Historic Growth

5.2.2. Market Consolidation Activities

5.2.3. New Enzyme Launches / Approvals

5.2.4. Increasing Demand of Proteinase K

5.2.5. Increasing Awareness Among People

5.2.6. Low Production Cost

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID-19 Crisis – Impact Assessment

6.1. COVID-19 and Impact Analysis

6.1.1. By Form

6.1.2. By Application

6.1.3. By End User

6.1.4. By Region

6.2. 2021 Market Scenario&

7. Global Market Demand Value or Size (US$ Mn) Analysis 2014 – 2021 and Forecast, 2022–2032

7.1. Historical Market Value (US$ Mn) Analysis, 2014 – 2021

7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2014– 2021 and Forecast 2022–2032, By Form

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis by Form, 2014 – 2021

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Form, 2022–2032

8.3.1. Lyophilized Powder Form

8.3.2. Liquid Form

8.4. Market Attractiveness Analysis by Form

9. Global Market Analysis 2014– 2021 and Forecast 2022–2032, By Application

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) By Application, 2014 – 2021

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application, 2022–2032

9.3.1. Isolation and Purification of Genomic DNA & RNA

9.3.2. In situ Hybridization

9.3.3. Mitochondria Isolation

9.3.4. Enzyme Removal

9.4. Market Attractiveness Analysis by Form

10. Global Market Analysis 2014 – 2021 and Forecast 2022–2032, By End User

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) By End User, 2014 – 2021

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2022–2032

10.3.1. Contract Research Organization

10.3.2. Academic Institutes

10.3.3. Biotechnology Companies

10.3.4. Diagnostic Laboratories

10.4. Market Attractiveness Analysis by End User

11. Global Market Analysis 2014 – 2021 and Forecast 2022–2032, By Region

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis by Region, 2014 – 2021

11.3. Current Market Size (US$ Mn) and Forecast by Region, 2022–2032

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. East Asia

11.3.5. South Asia

11.3.6. Oceania

11.3.7. Middle East and Africa (MEA)

11.4. Market Attractiveness Analysis by Region

12. North America Market Analysis 2014 – 2021 and Forecast 2022–2032

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014 – 2021

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022–2032

12.3.1. By Country

12.3.1.1. U.S.

12.3.1.2. Canada

12.3.2. By Form

12.3.3. By Application

12.3.4. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Form

12.4.3. By Application

12.4.4. By End User

12.5. Market Trends

12.6. Key Market Participants - Intensity Mapping

12.7. Drivers and Restraints - Impact Analysis

12.8. Country Level Analysis & Forecast

12.8.1. U.S. Market Analysis

12.8.1.1. Introduction

12.8.1.2. Market Analysis and Forecast by Market Taxonomy

12.8.1.2.1. By Form

12.8.1.2.2. By Application

12.8.1.2.3. By End User

12.8.2. Canada Market Analysis

12.8.2.1. Introduction

12.8.2.2. Market Analysis and Forecast by Market Taxonomy

12.8.2.2.1. By Form

12.8.2.2.2. By Application

12.8.2.2.3. By End User

13. Latin America Market Analysis 2014 – 2021 and Forecast 2022–2032

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014 – 2021

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022–2032

13.3.1. By Country

13.3.1.1. Mexico

13.3.1.2. Brazil

13.3.1.3. Argentina

13.3.1.4. Rest of Latin America

13.3.2. By Form

13.3.3. By Application

13.3.4. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Form

13.4.3. By Application

13.4.4. By End User

13.5. Market Trends

13.6. Key Market Participants - Intensity Mapping

13.7. Drivers and Restraints - Impact Analysis

13.8. Country Level Analysis & Forecast

13.8.1. Mexico Market Analysis

13.8.1.1. Introduction

13.8.1.2. Market Analysis and Forecast by Market Taxonomy

13.8.1.2.1. By Form

13.8.1.2.2. By Application

13.8.1.2.3. By End User

13.8.2. Brazil Market Analysis

13.8.2.1. Introduction

13.8.2.2. Market Analysis and Forecast by Market Taxonomy

13.8.2.2.1. By Form

13.8.2.2.2. By Application

13.8.2.2.3. By End User

13.8.3. Argentina Market Analysis

13.8.3.1. Introduction

13.8.3.2. Market Analysis and Forecast by Market Taxonomy

13.8.3.2.1. By Form

13.8.3.2.2. By Application

13.8.3.2.3. By End User

14. Europe Market Analysis 2014 – 2021 and Forecast 2022–2032

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014 – 2021

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022–2032

14.3.1. By Country

14.3.1.1. Germany

14.3.1.2. Italy

14.3.1.3. France

14.3.1.4. U.K.

14.3.1.5. Spain

14.3.1.6. BENELUX

14.3.1.7. Russia

14.3.1.8. Rest of Europe

14.3.2. By Form

14.3.3. By Application

14.3.4. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Form

14.4.3. By Application

14.4.4. By End User

14.5. Market Trends

14.6. Key Market Participants - Intensity Mapping

14.7. Drivers and Restraints - Impact Analysis

14.8. Country Level Analysis & Forecast

14.8.1. Germany Market Analysis

14.8.1.1. Introduction

14.8.1.2. Market Analysis and Forecast by Market Taxonomy

14.8.1.2.1. By Form

14.8.1.2.2. By Application

14.8.1.2.3. By End User

14.8.2. Italy Market Analysis

14.8.2.1. Introduction

14.8.2.2. Market Analysis and Forecast by Market Taxonomy

14.8.2.2.1. By Form

14.8.2.2.2. By Application

14.8.2.2.3. By End User

14.8.3. France Market Analysis

14.8.3.1. Introduction

14.8.3.2. Market Analysis and Forecast by Market Taxonomy

14.8.3.2.1. By Form

14.8.3.2.2. By Application

14.8.3.2.3. By End User

14.8.4. U.K. Market Analysis

14.8.4.1. Introduction

14.8.4.2. Market Analysis and Forecast by Market Taxonomy

14.8.4.2.1. By Form

14.8.4.2.2. By Application

14.8.4.2.3. By End User

14.8.5. Spain Market Analysis

14.8.5.1. Introduction

14.8.5.2. Market Analysis and Forecast by Market Taxonomy

14.8.5.2.1. By Form

14.8.5.2.2. By Application

14.8.5.2.3. By End User

14.8.6. BENELUX Market Analysis

14.8.6.1. Introduction

14.8.6.2. Market Analysis and Forecast by Market Taxonomy

14.8.6.2.1. By Form

14.8.6.2.2. By Application

14.8.6.2.3. By End User

14.8.7. Russia Market Analysis

14.8.7.1. Introduction

14.8.7.2. Market Analysis and Forecast by Market Taxonomy

14.8.7.2.1. By Form

14.8.7.2.2. By Application

14.8.7.2.3. By End User

15. East Asia Market Analysis 2014 – 2021 and Forecast 2022–2032

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014 – 2021

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022–2032

15.3.1. By Country

15.3.1.1. China

15.3.1.2. Japan

15.3.1.3. South Korea

15.3.2. By Form

15.3.3. By Application

15.3.4. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Form

15.4.3. By Application

15.4.4. By End User ;

15.5. Market Trends

15.6. Key Market Participants - Intensity Mapping

15.7. Drivers and Restraints - Impact Analysis

15.8. Country Level Analysis & Forecast

15.8.1. China Market Analysis

15.8.1.1. Introduction

15.8.1.2. Market Analysis and Forecast by Market Taxonomy

15.8.1.2.1. By Form

15.8.1.2.2. By Application

15.8.1.2.3. By End User

15.8.2. Japan Market Analysis

15.8.2.1. Introduction

15.8.2.2. Market Analysis and Forecast by Market Taxonomy

15.8.2.2.1. By Form

15.8.2.2.2. By Application

15.8.2.2.3. By End User

15.8.3. South Korea Market Analysis

15.8.3.1. Introduction

15.8.3.2. Market Analysis and Forecast by Market Taxonomy

15.8.3.2.1. By Form

15.8.3.2.2. By Application

15.8.3.2.3. By End User

16. South Asia Market Analysis 2014 – 2021 and Forecast 2022–2032

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend by Market Taxonomy, 2014 – 2021

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022–2032

16.3.1. By Country

16.3.1.1. India

16.3.1.2. Indonesia

16.3.1.3. Malaysia

16.3.1.4. Thailand

16.3.1.5. Rest of South Asia

16.3.2. By Form

16.3.3. By Application

16.3.4. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Form

16.4.3. By Application

16.4.4. By End User /p>

16.5. Market Trends

16.6. Key Market Participants - Intensity Mapping

16.7. Drivers and Restraints - Impact Analysis

16.8. Country Level Analysis & Forecast

16.8.1. India Market Analysis

16.8.1.1. Introduction

16.8.1.2. Market Analysis and Forecast by Market Taxonomy

16.8.1.2.1. By Form

16.8.1.2.2. By Application

16.8.1.2.3. By End User

16.8.2. Indonesia Market Analysis

16.8.2.1. Introduction

16.8.2.2. Market Analysis and Forecast by Market Taxonomy

16.8.2.2.1. By Form

16.8.2.2.2. By Application

16.8.2.2.3. By End User

16.8.3. Malaysia Market Analysis

16.8.3.1. Introduction

16.8.3.2. Market Analysis and Forecast by Market Taxonomy

16.8.3.2.1. By Form

16.8.3.2.2. By Application

16.8.3.2.3. By End User

16.8.4. Thailand Market Analysis

16.8.4.1. Introduction

16.8.4.2. Market Analysis and Forecast by Market Taxonomy

16.8.4.2.1. By Form

16.8.4.2.2. By Application

16.8.4.2.3. By End User

17. Oceania Market 2014-2021 and Forecast 2022-2032

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014 – 2021

17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022–2032

17.3.1. By Country

17.3.1.1. Australia

17.3.1.2. New Zealand

17.3.2. By Form

17.3.3. By Application

17.3.4. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Form

17.4.3. By Application

17.4.4. By End User

17.5. Market Trends

17.6. Key Market Participants - Intensity Mapping

17.7. Drivers and Restraints - Impact Analysis

17.8. Country Level Analysis & Forecast

17.8.1. Australia Market Analysis

17.8.1.1. Introduction

17.8.1.2. Market Analysis and Forecast by Market Taxonomy

17.8.1.2.1. By Form

17.8.1.2.2. By Application

17.8.1.2.3. By End User

17.8.2. New Zealand Market Analysis

17.8.2.1. Introduction

17.8.2.2. Market Analysis and Forecast by Market Taxonomy

17.8.2.2.1. By Form

17.8.2.2.2. By Application

17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2014 – 2021 and Forecast 2022–2032

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2014 – 2021

18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022–2032

18.3.1. By Country

18.3.1.1. GCC Countries

18.3.1.2. Turkey

18.3.1.3. South Africa

18.3.1.4. North Africa

18.3.1.5. Rest of Middle East and Africa

18.3.2. By Form

18.3.3. By Application

18.3.4. By End User

18.4. Market Attractiveness Analysis

18.4.1. By Country

18.4.2. By Form

18.4.3. By Application

18.4.4. By End User ;

18.5. Market Trends

18.6. Key Market Participants - Intensity Mapping

18.7. Drivers and Restraints - Impact Analysis

18.8. Country Level Analysis & Forecast

18.8.1. GCC Countries Market Analysis

18.8.1.1. Introduction

18.8.1.2. Market Analysis and Forecast by Market Taxonomy

18.8.1.2.1. By Form

18.8.1.2.2. By Application

18.8.1.2.3. By End User

18.8.2. Turkey Market Analysis

18.8.2.1. Introduction

18.8.2.2. Market Analysis and Forecast by Market Taxonomy

18.8.2.2.1. By Form

18.8.2.2.2. By Application

18.8.2.2.3. By End User

18.8.3. South Africa Market Analysis

18.8.3.1. Introduction

18.8.3.2. Market Analysis and Forecast by Market Taxonomy

18.8.3.2.1. By Form

18.8.3.2.2. By Application

18.8.3.2.3. By End User

18.8.4. North Africa Market Analysis

18.8.4.1. Introduction

18.8.4.2. Market Analysis and Forecast by Market Taxonomy

18.8.4.2.1. By Form

18.8.4.2.2. By Application

18.8.4.2.3. By End User

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies

19.2. Market Share Analysis of Top Players (%)

19.3. Market Presence Analysis

19.3.1. By Regional Footprint of Players

19.3.2. Product Footprint of Players

19.3.3. Channel Footprint of Players

20. Competition Analysis

20.1. Competition Dashboard

20.2. Competition Benchmarking

20.3. Competition Deep Dive ;

20.3.1. Thermo Fisher Scientific Inc.

20.3.1.1. Overview

20.3.1.2. Form & Services Portfolio

20.3.1.3. Key Financials

20.3.1.4. SWOT Analysis

20.3.1.5. Key Developments

20.3.1.6. Sales Footprint

20.3.1.7. Strategy Overview

20.3.1.7.1. Marketing Strategy

20.3.1.7.2. Product Strategy

20.3.1.7.3. Channel Strategy

20.3.2. Merck KGaA

20.3.2.1. Overview

20.3.2.2. Form & Services Portfolio

20.3.2.3. Key Financials

20.3.2.4. SWOT Analysis

20.3.2.5. Key Developments

20.3.2.6. Sales Footprint

20.3.2.7. Strategy Overview

20.3.2.7.1. Marketing Strategy

20.3.2.7.2. Product Strategy

20.3.2.7.3. Channel Strategy

20.3.3. Qiagen N.V.

20.3.3.1. Overview

20.3.3.2. Form & Services Portfolio

20.3.3.3. Key Financials

20.3.3.4. SWOT Analysis

20.3.3.5. Key Developments

20.3.3.6. Sales Footprint

20.3.3.7. Strategy Overview

20.3.3.7.1. Marketing Strategy

20.3.3.7.2. Product Strategy

20.3.3.7.3. Channel Strategy

20.3.4. F. Hoffmann-La Roche Ltd.

20.3.4.1. Overview

20.3.4.2. Form & Services Portfolio

20.3.4.3. Key Financials

20.3.4.4. SWOT Analysis

20.3.4.5. Key Developments

20.3.4.6. Sales Footprint

20.3.4.7. Strategy Overview

20.3.4.7.1. Marketing Strategy

20.3.4.7.2. Product Strategy

20.3.4.7.3. Channel Strategy

20.3.5. New England Biolabs

20.3.5.1. Overview

20.3.5.2. Form & Services Portfolio

20.3.5.3. Key Financials

20.3.5.4. SWOT Analysis

20.3.5.5. Key Developments

20.3.5.6. Sales Footprint

20.3.5.7. Strategy Overview

20.3.5.7.1. Marketing Strategy

20.3.5.7.2. Product Strategy

20.3.5.7.3. Channel Strategy

20.3.6. Worthington Biochemical Corporation

20.3.6.1. Overview

20.3.6.2. Form & Services Portfolio

20.3.6.3. Key Financials

20.3.6.4. SWOT Analysis

20.3.6.5. Key Developments

20.3.6.6. Sales Footprint

20.3.6.7. Strategy Overview

20.3.6.7.1. Marketing Strategy

20.3.6.7.2. Product Strategy

20.3.6.7.3. Channel Strategy

20.3.7. Norgen Biotek Corp.

20.3.7.1. Overview

20.3.7.2. Form & Services Portfolio

20.3.7.3. Key Financials

20.3.7.4. SWOT Analysis

20.3.7.5. Key Developments

20.3.7.6. Sales Footprint

20.3.7.7. Strategy Overview

20.3.7.7.1. Marketing Strategy

20.3.7.7.2. Product Strategy

20.3.7.7.3. Channel Strategy

20.3.8. BIORON GmbH

20.3.8.1. Overview

20.3.8.2. Form & Services Portfolio

20.3.8.3. Key Financials

20.3.8.4. SWOT Analysis

20.3.8.5. Key Developments

20.3.8.6. Sales Footprint

20.3.8.7. Strategy Overview

20.3.8.7.1. Marketing Strategy

20.3.8.7.2. Product Strategy

20.3.8.7.3. Channel Strategy

20.3.9. SdsManager

20.3.9.1. Overview

20.3.9.2. Form & Services Portfolio

20.3.9.3. Key Financials

20.3.9.4. SWOT Analysis

20.3.9.5. Key Developments

20.3.9.6. Sales Footprint

20.3.9.7. Strategy Overview

20.3.9.7.1. Marketing Strategy

20.3.9.7.2. Product Strategy

20.3.9.7.3. Channel Strategy

20.3.10. Sisco Research Laboratories Pvt. Ltd.

20.3.10.1. Overview

20.3.10.2. Form & Services Portfolio

20.3.10.3. Key Financials

20.3.10.4. SWOT Analysis

20.3.10.5. Key Developments

20.3.10.6. Sales Footprint

20.3.10.7. Strategy Overview

20.3.10.7.1. Marketing Strategy

20.3.10.7.2. Product Strategy

20.3.10.7.3. Channel Strategy

20.3.11. Bioline (Meridian Biosciences Inc.)

20.3.11.1. Overview

20.3.11.2. Form & Services Portfolio

20.3.11.3. Key Financials

20.3.11.4. SWOT Analysis

20.3.11.5. Key Developments

20.3.11.6. Sales Footprint

20.3.11.7. Strategy Overview

20.3.11.7.1. Marketing Strategy

20.3.11.7.2. Product Strategy

20.3.11.7.3. Channel Strategy

20.3.12. Promega Corporation

20.3.12.1. Overview

20.3.12.2. Form & Services Portfolio

20.3.12.3. Key Financials

20.3.12.4. SWOT Analysis

20.3.12.5. Key Developments

20.3.12.6. Sales Footprint

20.3.12.7. Strategy Overview

20.3.12.7.1. Marketing Strategy

20.3.12.7.2. Product Strategy

20.3.12.7.3. Channel Strategy

20.3.13. Codexis, Inc.

20.3.13.1. Overview

20.3.13.2. Form & Services Portfolio

20.3.13.3. Key Financials

20.3.13.4. SWOT Analysis

20.3.13.5. Key Developments

20.3.13.6. Sales Footprint

20.3.13.7. Strategy Overview

20.3.13.7.1. Marketing Strategy

20.3.13.7.2. Product Strategy

20.3.13.7.3. Channel Strategy

20.3.14. Amano Enzyme Inc.

20.3.14.1. Overview

20.3.14.2. Form & Services Portfolio

20.3.14.3. Key Financials

20.3.14.4. SWOT Analysis

20.3.14.5. Key Developments

20.3.14.6. Sales Footprint

20.3.14.7. Strategy Overview

20.3.14.7.1. Marketing Strategy

20.3.14.7.2. Product Strategy

20.3.14.7.3. Channel Strategy

20.3.15. Advanced Enzymes Technologies Ltd.

20.3.15.1. Overview

20.3.15.2. Form & Services Portfolio

20.3.15.3. Key Financials

20.3.15.4. SWOT Analysis

20.3.15.5. Key Developments

20.3.15.6. Sales Footprint

20.3.15.7. Strategy Overview

20.3.15.7.1. Marketing Strategy

20.3.15.7.2. Product Strategy

20.3.15.7.3. Channel Strategy

20.3.16. Biocatalysts Ltd.

20.3.16.1. Overview

20.3.16.2. Form & Services Portfolio

20.3.16.3. Key Financials

20.3.16.4. SWOT Analysis

20.3.16.5. Key Developments

20.3.16.6. Sales Footprint

20.3.16.7. Strategy Overview

20.3.16.7.1. Marketing Strategy

20.3.16.7.2. Product Strategy

20.3.16.7.3. Channel Strategy

20.3.17. Amicogen

20.3.17.1. Overview

20.3.17.2. Form & Services Portfolio

20.3.17.3. Key Financials

20.3.17.4. SWOT Analysis

20.3.17.5. Key Developments

20.3.17.6. Sales Footprint

20.3.17.7. Strategy Overview

20.3.17.7.1. Marketing Strategy

20.3.17.7.2. Product Strategy

20.3.17.7.3. Channel Strategy

20.3.18. Dyadic International

20.3.18.1. Overview

20.3.18.2. Form & Services Portfolio

20.3.18.3. Key Financials

20.3.18.4. SWOT Analysis

20.3.18.5. Key Developments

20.3.18.6. Sales Footprint

20.3.18.7. Strategy Overview

20.3.18.7.1. Marketing Strategy

20.3.18.7.2. Product Strategy

20.3.18.7.3. Channel Strategy

20.3.19. BBI Solutions

20.3.19.1. Overview

20.3.19.2. Form & Services Portfolio

20.3.19.3. Key Financials

20.3.19.4. SWOT Analysis

20.3.19.5. Key Developments

20.3.19.6. Sales Footprint

20.3.19.7. Strategy Overview

20.3.19.7.1. Marketing Strategy

20.3.19.7.2. Product Strategy

20.3.19.7.3. Channel Strategy

20.3.20. American Laboratories

20.3.20.1. Overview

20.3.20.2. Form & Services Portfolio

20.3.20.3. Key Financials

20.3.20.4. SWOT Analysis

20.3.20.5. Key Developments

20.3.20.6. Sales Footprint

20.3.20.7. Strategy Overview

20.3.20.7.1. Marketing Strategy

20.3.20.7.2. Product Strategy

20.3.20.7.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

Customize Now

List of Tables

Table 01: Global Market Analysis 2014–2021 and Forecast 2022–2032, By Form

Table 02: Global Market Analysis 2014–2021 and Forecast 2022–2032By Application

Table 03: Global Market Analysis 2014–2021 and Forecast 2022–2032, By End User

Table 04: Global Market Analysis 2014–2021 and Forecast 2022–2032, By Region

Table 05: North America Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Country

Table 06: North America Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Form

Table 07: North America Market Analysis 2014–2021 and Forecast 2022–2032By Application

Table 08: North America Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By End User

Table 09: Latin America Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Country

Table 10: Latin America Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Form

Table 11: Latin America Market Analysis 2014–2021 and Forecast 2022–2032By Application

Table 12: Latin America Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By End User

Table 13: Europe Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Country

Table 14: Europe Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Form

Table 15: Europe Market Analysis 2014–2021 and Forecast 2022–2032By Application

Table 16: Europe Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By End User

Table 17: East Asia Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Country

Table 18: East Asia Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Form

Table 19: East Asia Market Analysis 2014–2021 and Forecast 2022–2032By Application

Table 20: East Asia Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By End User

Table 21: South Asia Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Country

Table 22: South Asia Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Form

Table 23: South Asia Market Analysis 2014–2021 and Forecast 2022–2032By Application

Table 24: South Asia Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By End User

Table 25: Oceania Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Country

Table 26: Oceania Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Form

Table 27: Oceania Market Analysis 2014–2021 and Forecast 2022–2032By Application

Table 28: Oceania Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By End User

Table 29: Middle East & Africa Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Country

Table 30: Middle East & Africa Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By Form

Table 31: Middle East & Africa Market Analysis 2014–2021 and Forecast 2022–2032By Application

Table 32: Middle East & Africa Market Value (US$ Mn) Analysis 2014–2021 and Forecast 2022–2032, By End User

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Value Analysis, 2014–2021

Figure 02: Global Market Forecast & Y-o-Y Growth, 2022–2032

Figure 03: Global Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032

Figure 04: Global Market Value Share (%) Analysis 2022 and 2032, By Form

Figure 05: Global Market Y-o-Y Growth (%) Analysis 2021-2032, By Form

Figure 06: Global Market Attractiveness Analysis 2022–2032, By Form

Figure 07: Global Market Value Share (%) Analysis 2022 and 2032, By Application

Figure 08: Global Market Y-o-Y Growth (%) Analysis 2021-2032, By Application

Figure 09: Global Market Attractiveness Analysis 2022–2032, By Application

Figure 10: Global Market Value Share (%) Analysis 2022 and 2032, By End User

Figure 11: Global Market Y-o-Y Growth (%) Analysis 2021-2032, By End User

Figure 12: Global Market Attractiveness Analysis 2022–2032, By End User

Figure 13: Global Market Value Share (%) Analysis 2022 and 2032, By Region

Figure 14: Global Market Y-o-Y Growth (%) Analysis 2021-2032, By Region

Figure 15: Global Market Attractiveness Analysis 2022–2032, By Region

Figure 16: North America Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 17: North America Market Y-o-Y Analysis, 2022-2032

Figure 18: North America Market Value Analysis, 2014–2021

Figure 19: North America Market Forecast & Y-o-Y growth, 2022–2032

Figure 20: North America Market Value Share, By Form (2022 E)

Figure 21: North America Market Value Share, By Application (2022 E)

Figure 22: North America Market Value Share, By End User (2022 E)

Figure 23: North America Market Value Share, By Country (2022 E)

Figure 24: North America Market Attractiveness Analysis by Form, 2022–2032

Figure 25: North America Market Attractiveness Analysis by Application, 2022–2032

Figure 26: North America Market Attractiveness Analysis by End User, 2022–2032

Figure 27: North America Market Attractiveness Analysis by Country, 2022–2032

Figure 28: U.S. Market Value Proportion Analysis, 2021

Figure 29: U.S. Market Share Analysis (%) By Form, 2021 & 2032

Figure 30: U.S. Market Share Analysis (%) By Application, 2021 & 2032

Figure 31: U.S. Market Share Analysis (%) By End User, 2021 & 2032

Figure 32: Global Vs. U.S. Growth Comparison

Figure 33: Canada Market Value Proportion Analysis, 2021

Figure 34: Canada Market Share Analysis (%) By Form, 2021 & 2032

Figure 35: Canada Market Share Analysis (%) By Application, 2021 & 2032

Figure 36: Canada Market Share Analysis (%) By End User, 2021 & 2032

Figure 37: Global Vs. Canada. Growth Comparison

Figure 38: Latin America Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 39: Latin America Market Y-o-Y Analysis, 2022-2032

Figure 40: Latin America Market Value Analysis, 2014–2021

Figure 41: Latin America Market Forecast & Y-o-Y growth, 2022–2032

Figure 42: Latin America Market Value Share, By Form (2022 E)

Figure 43: Latin America Market Value Share, By Application (2022 E)

Figure 44: Latin America Market Value Share, By End User (2022 E)

Figure 45: Latin America Market Value Share, By Country (2022 E)

Figure 46: Latin America Market Attractiveness Analysis by Form, 2022–2032

Figure 47: Latin America Market Attractiveness Analysis by Application, 2022–2032

Figure 48: Latin America Market Attractiveness Analysis by End User, 2022–2032

Figure 49: Latin America Market Attractiveness Analysis by Country, 2022–2032

Figure 50: Mexico Market Value Proportion Analysis, 2021

Figure 51: Mexico Market Share Analysis (%) By Form, 2021 & 2032

Figure 52: Mexico Market Share Analysis (%) By Application, 2021 & 2032

Figure 53: Mexico Market Share Analysis (%) By End User, 2021 & 2032

Figure 54: Global Vs Mexico Growth Comparison

Figure 55: Brazil Market Value Proportion Analysis, 2021

Figure 56: Brazil Market Share Analysis (%) By Form, 2021 & 2032

Figure 57: Brazil Market Share Analysis (%) By Application, 2021 & 2032

Figure 58: Brazil Market Share Analysis (%) By End User, 2021 & 2032

Figure 59: Global Vs. Brazil. Growth Comparison

Figure 60: Argentina Market Value Proportion Analysis, 2021

Figure 61: Argentina Market Share Analysis (%) By Form, 2021 & 2032

Figure 62: Argentina Market Share Analysis (%) By Application, 2021 & 2032

Figure 63: Argentina Market Share Analysis (%) By End User, 2021 & 2032

Figure 64: Global Vs Argentina Growth Comparison

Figure 65: Europe Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 66: Europe Market Y-o-Y Analysis, 2022-2032

Figure 67: Europe Market Value Analysis, 2014–2021

Figure 68: Europe Market Forecast & Y-o-Y growth, 2022–2032

Figure 69: Europe Market Value Share, By Form (2022 E)

Figure 70: Europe Market Value Share, By Application (2022 E)

Figure 71: Europe Market Value Share, By End User (2022 E)

Figure 72: Europe Market Value Share, By Country (2022 E)

Figure 73: Europe Market Attractiveness Analysis by Form, 2022–2032

Figure 74: Europe Market Attractiveness Analysis by Application, 2022–2032

Figure 75: Europe Market Attractiveness Analysis by End User, 2022–2032

Figure 76: Europe Market Attractiveness Analysis by Country, 2022–2032

Figure 77: U.K. Market Value Proportion Analysis, 2021

Figure 78: U.K. Market Share Analysis (%) By Form, 2021 & 2032

Figure 79: U.K. Market Share Analysis (%) By Application, 2021 & 2032

Figure 80: U.K. Market Share Analysis (%) By End User, 2021 & 2032

Figure 81: Global Vs. U.K. Growth Comparison

Figure 82: Germany Market Value Proportion Analysis, 2021

Figure 83: Germany Market Share Analysis (%) By Form, 2021 & 2032

Figure 84: Germany Market Share Analysis (%) By Application, 2021 & 2032

Figure 85: Germany Market Share Analysis (%) By End User, 2021 & 2032

Figure 86: Global Vs. Germany Growth Comparison

Figure 87: Italy Market Value Proportion Analysis, 2021

Figure 88: Italy Market Share Analysis (%) By Form, 2021 & 2032

Figure 89: Italy Market Share Analysis (%) By Application, 2021 & 2032

Figure 90: Italy Market Share Analysis (%) By End User, 2021 & 2032

Figure 91: Global Vs. Italy Growth Comparison

Figure 92: France Market Value Proportion Analysis, 2021

Figure 93: France Market Share Analysis (%) By Form, 2021 & 2032

Figure 94: France Market Share Analysis (%) By Application, 2021 & 2032

Figure 95: France Market Share Analysis (%) By End User, 2021 & 2032

Figure 96: Global Vs France Growth Comparison

Figure 97: Spain Market Value Proportion Analysis, 2021

Figure 98: Spain Market Share Analysis (%) By Form, 2021 & 2032

Figure 99: Spain Market Share Analysis (%) By Application, 2021 & 2032

Figure 100: Spain Market Share Analysis (%) By End User, 2021 & 2032

Figure 101: Global Vs Spain Growth Comparison

Figure 102: Russia Market Value Proportion Analysis, 2021

Figure 103: Russia Market Share Analysis (%) By Form, 2021 & 2032

Figure 104: Russia Market Share Analysis (%) By Application, 2021 & 2032

Figure 105: Russia Market Share Analysis (%) By End User, 2021 & 2032

Figure 106: Global Vs Russia Growth Comparison

Figure 107: BENELUX Market Value Proportion Analysis, 2021

Figure 108: BENELUX Market Share Analysis (%) By Form, 2021 & 2032

Figure 109: BENELUX Market Share Analysis (%) By Application, 2021 & 2032

Figure 110: BENELUX Market Share Analysis (%) By End User, 2021 & 2032

Figure 111: Global Vs BENELUX Growth Comparison

Figure 112: East Asia Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 113: East Asia Market Y-o-Y Analysis, 2022-2032

Figure 114: East Asia Market Value Analysis, 2014–2021

Figure 115: East Asia Market Forecast & Y-o-Y growth, 2022–2032

Figure 116: East Asia Market Value Share, By Form (2022 E)

Figure 117: East Asia Market Value Share, By Application (2022 E)

Figure 118: East Asia Market Value Share, By End User (2022 E)

Figure 119: East Asia Market Value Share, By Country (2022 E)

Figure 120: East Asia Market Attractiveness Analysis by Form, 2022–2032

Figure 121: East Asia Market Attractiveness Analysis by Application, 2022–2032

Figure 122: East Asia Market Attractiveness Analysis by End User, 2022–2032

Figure 123: East Asia Market Attractiveness Analysis by Country, 2022–2032

Figure 124: China Market Value Proportion Analysis, 2021

Figure 125: China Market Share Analysis (%) By Form, 2021 & 2032

Figure 126: China Market Share Analysis (%) By Application, 2021 & 2032

Figure 127: China Market Share Analysis (%) By End User, 2021 & 2032

Figure 128: Global Vs. China Growth Comparison

Figure 129: Japan Market Value Proportion Analysis, 2021

Figure 130: Japan Market Share Analysis (%) By Form, 2021 & 2032

Figure 131: Japan Market Share Analysis (%) By Application, 2021 & 2032

Figure 132: Japan Market Share Analysis (%) By End User, 2021 & 2032

Figure 133: Global Vs. Japan Growth Comparison

Figure 134: South Korea Market Value Proportion Analysis, 2021

Figure 135: South Korea Market Share Analysis (%) By Form, 2021 & 2032

Figure 136: South Korea Market Share Analysis (%) By Application, 2021 & 2032

Figure 137: South Korea Market Share Analysis (%) By End User, 2021 & 2032

Figure 138: Global Vs South Korea Growth Comparison

Figure 139: South Asia Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 140: South Asia Market Y-o-Y Analysis, 2022-2032

Figure 141: South Asia Market Value Analysis, 2014–2021

Figure 142: South Asia Market Forecast & Y-o-Y growth, 2022–2032

Figure 143: South Asia Market Value Share, By Form (2022 E)

Figure 144: South Asia Market Value Share, By Application (2022 E)

Figure 145: South Asia Market Value Share, By End User (2022 E)

Figure 146: South Asia Market Value Share, By Country (2022 E)

Figure 147: South Asia Market Attractiveness Analysis by Form, 2022–2032

Figure 148: South Asia Market Attractiveness Analysis by Application, 2022–2032

Figure 149: South Asia Market Attractiveness Analysis by End User, 2022–2032

Figure 150: South Asia Market Attractiveness Analysis by Country, 2022–2032

Figure 151: India Market Value Proportion Analysis, 2021

Figure 152: India Market Share Analysis (%) By Form, 2021 & 2032

Figure 153: India Market Share Analysis (%) By Application, 2021 & 2032

Figure 154: India Market Share Analysis (%) By End User, 2021 & 2032

Figure 155: Global Vs. India Growth Comparison

Figure 156: Indonesia Market Value Proportion Analysis, 2021

Figure 157: Indonesia Market Share Analysis (%) By Form, 2021 & 2032

Figure 158: Indonesia Market Share Analysis (%) By Application, 2021 & 2032

Figure 159: Indonesia Market Share Analysis (%) By End User, 2021 & 2032

Figure 160: Global Vs. Indonesia Growth Comparison

Figure 161: Malaysia Market Value Proportion Analysis, 2021

Figure 162: Malaysia Market Share Analysis (%) By Form, 2021 & 2032

Figure 163: Malaysia Market Share Analysis (%) By Application, 2021 & 2032

Figure 164: Malaysia Market Share Analysis (%) By End User, 2021 & 2032

Figure 165: Global Vs. Malaysia Growth Comparison

Figure 166: Thailand Market Value Proportion Analysis, 2021

Figure 167: Thailand Market Share Analysis (%) By Form, 2021 & 2032

Figure 168: Thailand Market Share Analysis (%) By Application, 2021 & 2032

Figure 169: Thailand Market Share Analysis (%) By End User, 2021 & 2032

Figure 170: Global Vs. Thailand Growth Comparison

Figure 171: Oceania Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 172: Oceania Market Y-o-Y Analysis, 2022-2032

Figure 173: Oceania Market Value Analysis, 2014–2021

Figure 174: Oceania Market Forecast & Y-o-Y growth, 2022–2032

Figure 175: Oceania Market Value Share, By Form (2022 E)

Figure 176: Oceania Market Value Share, By Application (2022 E)

Figure 177: Oceania Market Value Share, By End User (2022 E)

Figure 178: Oceania Market Value Share, By Country (2022 E)

Figure 179: Oceania Market Attractiveness Analysis by Form, 2022–2032

Figure 180: Oceania Market Attractiveness Analysis by Application, 2022–2032

Figure 181: Oceania Market Attractiveness Analysis by End User, 2022–2032

Figure 182: Oceania Market Attractiveness Analysis by Country, 2022–2032

Figure 183: Australia Market Value Proportion Analysis, 2021

Figure 184: Australia Market Share Analysis (%) By Form, 2021 & 2032

Figure 185: Australia Market Share Analysis (%) By Application, 2021 & 2032

Figure 186: Australia Market Share Analysis (%) By End User, 2021 & 2032

Figure 187: Global Vs. Australia Growth Comparison

Figure 188: New Zealand Market Value Proportion Analysis, 2021

Figure 189: New Zealand Market Share Analysis (%) By Form, 2021 & 2032

Figure 190: New Zealand Market Share Analysis (%) By Application, 2021 & 2032

Figure 191: New Zealand Market Share Analysis (%) By End User, 2021 & 2032

Figure 192: Global Vs New Zealand Growth Comparison

Figure 193: Middle East & Africa Market Size (US$ Mn) Analysis, 2022E & 2032F

Figure 194: Middle East & Africa Market Y-o-Y Analysis, 2022-2032

Figure 195: Middle East & Africa Market Value Analysis, 2014–2021

Figure 196: Middle East & Africa Market Forecast & Y-o-Y growth, 2022–2032

Figure 197: Middle East & Africa Market Value Share, By Form (2022 E)

Figure 198: Middle East & Africa Market Value Share, By Application (2022 E)

Figure 199: Middle East & Africa Market Value Share, By End User (2022 E)

Figure 200: Middle East & Africa Market Value Share, By Country (2022 E)

Figure 201: Middle East & Africa Market Attractiveness Analysis by Form, 2022–2032

Figure 202: Middle East & Africa Market Attractiveness Analysis by Application, 2022–2032

Figure 203: Middle East & Africa Market Attractiveness Analysis by End User, 2022–2032

Figure 204: Middle East & Africa Market Attractiveness Analysis by Country, 2022–2032

Figure 205: GCC Countries Market Value Proportion Analysis, 2021

Figure 206: GCC Countries Market Share Analysis (%) By Form, 2021 & 2032

Figure 207: GCC Countries Market Share Analysis (%) By Application, 2021 & 2032

Figure 208: GCC Countries Market Share Analysis (%) By End User, 2021 & 2032

Figure 209: Global Vs GCC Countries Growth Comparison

Figure 210: Turkey Market Value Proportion Analysis, 2021

Figure 211: Turkey Market Share Analysis (%) By Form, 2021 & 2032

Figure 212: Turkey Market Share Analysis (%) By Application, 2021 & 2032

Figure 213: Turkey Market Share Analysis (%) By End User, 2021 & 2032

Figure 214: Global Vs. Turkey Growth Comparison

Figure 215: South Africa Market Value Proportion Analysis, 2021

Figure 216: South Africa Market Share Analysis (%) By Form, 2021 & 2032

Figure 217: South Africa Market Share Analysis (%) By Application, 2021 & 2032

Figure 218: South Africa Market Share Analysis (%) By End User, 2021 & 2032

Figure 219: Global Vs. South Africa Growth Comparison

Figure 220: North Africa Market Value Proportion Analysis, 2021

Figure 221: North Africa Market Share Analysis (%) By Form, 2021 & 2032

Figure 222: North Africa Market Share Analysis (%) By Application, 2021 & 2032

Figure 223: North Africa Market Share Analysis (%) By End User, 2021 & 2032

Figure 224: Global Vs North Africa Growth Comparison